Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1076" ]
    } ]
  },
  "date" : "2017-05-04T01:00:13-04:00",
  "meta" : {
    "versionId" : "14",
    "lastUpdated" : "2019-02-26T22:31:47.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "NCQA PHEMUR",
  "jurisdiction" : [ {
    "extension" : [ {
      "valueString" : "UNKNOWN",
      "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason"
    } ]
  } ],
  "purpose" : "(Clinical Focus: This value set contains concepts that represent Pneumocystis jiroveci pneumonia (PCP) prophylaxis medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Order.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable. Includes only relevant concepts associated with trimethoprim-sulfamethoxazole, dapsone, atovaquone, and pentamidine isethionate.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable; PCP prophylaxis medications in combination with other medications.)",
  "name" : "PneumocystisJiroveciPneumoniaPCPProphylaxis",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "142118",
      "display" : "sulfamethoxazole 100 MG / trimethoprim 20 MG Oral Tablet",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "197557",
      "display" : "dapsone 100 MG Oral Tablet",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "197558",
      "display" : "dapsone 25 MG Oral Tablet",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "198334",
      "display" : "sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "198335",
      "display" : "sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "308429",
      "display" : "atovaquone 150 MG/ML Oral Suspension",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "313134",
      "display" : "sulfamethoxazole 40 MG/ML / trimethoprim 8 MG/ML Oral Suspension",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "313137",
      "display" : "sulfamethoxazole 80 MG/ML / trimethoprim 16 MG/ML Injectable Solution",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "607295",
      "display" : "dapsone 0.05 MG/MG Topical Gel",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "861597",
      "display" : "pentamidine isethionate 50 MG/ML Inhalation Solution",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "861601",
      "display" : "pentamidine isethionate 300 MG Injection",
      "version" : "06052023"
    } ],
    "offset" : 0,
    "total" : 11,
    "identifier" : "urn:uuid:82c8c9d3-2237-4ed0-b0b3-45423b31529f",
    "timestamp" : "2023-06-29T19:19:39-04:00",
    "parameter" : [ {
      "name" : "count",
      "valueInteger" : 1000
    }, {
      "name" : "offset",
      "valueInteger" : 0
    } ]
  },
  "title" : "Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis",
  "extension" : [ {
    "valueString" : "NCQA PHEMUR Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2022-12-15",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2017-05-04",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "17a372c5-28e2-4de0-851a-fb2a2333eb3b",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1076",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.3.464.1003.196.12.1076"
  } ],
  "version" : "20170504"
}